API Dexmedetomidine Hydrochloride Manufactured by SSY Group was Approved

API Dexmedetomidine Hydrochloride Manufactured by SSY Group was Approved 

Recently API Dexmedetomidine Hydrochloride developed and applied by Hebei Guolong Pharmaceutical Co., Ltd., SSY Group was approved by NMPA to be used for the FPF.

FPF Dexmedetomidine Hydrochloride Injection (2ml:0.2mg) applied by SSY Group also got the MA from NMPA and treated as consistency evaluation completion. 

Dexmedetomidine is a α2 adrenergic receptor agonists, it is maily used for sedation during tracheal intubation and mechanical ventilation in patients undergoing surgery under general anesthesia.